Variables | Healthy Control Group (n = 32) | Untreated FMF Group (n = 25) | Treated FMF Group (n = 41) | Kruskal-Wallis test |
---|---|---|---|---|
Age (years) (mean ± SD) | 34.72 ± 9.07 | 32.82 ± 9.85 | 36.53 ± 10.98 | p = 0.528 |
Gender (male/female) | 10/22 | 8/17 | 13/28 | p = 0.983 |
Mean RNFL (μm) (mean ± SD) | 98.18 ± 1.89 | 98.17 ± 7.32 | 101.41 ± 8.44 | p = 0.231 |
Superior RNFL (μm) (mean ± SD) | 117.04 ± 2.21 | 115.52 ± 10.28 | 115.75 ± 10.00 | p = 0.583 |
Inferior RNFL (μm) (mean ± SD) | 123.72 ± 2.84 | 125.88 ± 13.77 | 128.04 ± 12.14 | p = 0.418 |
Temporal RNFL (μm) (mean ± SD) | 70.45 ± 6.32 | 72.23 ± 12.16 | 72.85 ± 10.83 | p = 0.817 |
Nasal RNFL (μm) (mean ± SD) | 81.27 ± 4.16 | 80.47 ± 11.53 | 86.12 ± 12.27 | p = 0.081 |